Komori
VALUENEX Japan (4422) · InitiativeAdvanced

Public Offering Capital Increases Accompanying Listings and Allocation of Proceeds to Growth Investments

First written in FY2018. 15 of 17 entries say "Advanced", first in FY2019-Q1. Latest entry: 2026-10-06.

17entries
9years
1from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseAdvancedFY2019-Q1 – FY2022-Q2AdvancedFY2023-Q1 – 2026-10-062018: 22019: 420192020: 320202021: 020212022: 320222023: 220232024: 020242025: 120252026: 22026
Same theme, other companies
Use of proceeds from the public offering for business expansion and growth investmentA theme 188 companies write about · 0 as a headwind · 196 as a tailwind

63 other companies' latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 188 companies compared. The sentences above are computed from all 188.
Full recordFilings, disclosures and news, newest first
  1. 2026-10-06AdvancedGeneral Meetings of Shareholders

    「新 株 の 発 行(新株予約権の行使) 252 252 504」

    当事業年度に新株予約権の行使による新株発行が行われ、資本金及び資本準備金がそれぞれ252千円増加したことが示されている。
  2. FY2026-H1AdvancedAnnual report

    「Between 1 February 2026 and 28 February 2026, the total number of issued shares increased by 12,600 through the exercise of stock acquisition rights, while capital and capital surplus each increased by ¥252,000.」

    Following the interim period, 12,600 shares were issued upon the exercise of stock acquisition rights, increasing capital and capital surplus by ¥252,000 each.
  3. FY2025-H1AdvancedAnnual report

    「1 August 2024–31 January 2025 2,000 2,895,300 622 81,866 622 433,324」

    2,000 shares were issued upon the exercise of stock acquisition rights, increasing capital and capital surplus by ¥622 thousand each.
  4. FY2023AdvancedAnnual report

    「The 4,000-share increase in the total number of issued common shares resulted from the exercise of stock acquisition rights.」

    During the fiscal year under review, 4,000 shares were issued upon the exercise of stock acquisition rights, increasing capital and capital surplus by ¥1,244 thousand each.
  5. FY2023-Q2AdvancedAnnual report

    「1 November 2022–31 January 2023 (Note) 1,000 2,893,300 311 81,244 311 432,702」

    1,000 shares were issued upon the exercise of stock acquisition rights, increasing capital and capital surplus by ¥311 thousand each.
  6. FY2023-Q1AdvancedAnnual report

    「1 August 2022–31 October 2022 (Note) 3,000 2,892,300 933 532,391 933 432,391」

    3,000 shares were issued upon the exercise of stock acquisition rights, increasing capital and capital surplus by ¥933 thousand each.
  7. FY2022RestatedAnnual report

    「1 August 2021–31 July 2022 (Note 4) 7,200 2,889,300 1,185 531,458 1,185 431,458」

    During the fiscal year under review, 7,200 shares were issued upon the exercise of stock acquisition rights, increasing capital and capital surplus by ¥1,185 thousand each. The capital-raising results reported through the previous quarter are being checked against the full-year table.
  8. FY2022-Q2AdvancedAnnual report

    「1 November 2021–31 January 2022 (Note) 7,200 2,889,300 1,185 531,458 1,185 431,458」

    7,200 shares were issued upon the exercise of stock acquisition rights, increasing capital and capital surplus by ¥1,185 thousand each.
  9. FY2021-Q1AdvancedAnnual report

    「1 August 2020–31 October 2020 (Note) 600 2,877,000 125 529,210 125 429,210」

    The exercise of stock acquisition rights resulted in the issuance of 600 shares and an increase of ¥125 thousand each in share capital and the capital surplus.
  10. FY2020AdvancedAnnual report

    「The 20,100-share increase in the total number of issued common shares resulted from the exercise of stock acquisition rights.」

    During the fiscal year, 20,100 shares were issued through the exercise of stock acquisition rights, increasing share capital and the capital surplus by ¥6.189 million each.
  11. FY2020-Q3AdvancedAnnual report

    「1 February 2020–30 April 2020 (Note) 3,000 2,876,400 933 529,084 933 429,084」

    The exercise of stock acquisition rights during the third quarter resulted in the issuance of 3,000 shares and an increase of ¥933 thousand each in share capital and the capital surplus.
  12. FY2020-Q1AdvancedAnnual report

    「Note: The increase resulted from the exercise of stock acquisition rights.」

    Between 1 August 2019 and 31 October 2019, the total number of issued shares increased by 17,100 shares through the exercise of stock acquisition rights, while share capital and the capital surplus each increased by ¥5.256 million.
  13. FY2019AdvancedAnnual report

    「Funds generated from financing activities during the fiscal year amounted to ¥749.430 million, compared with ¥35.569 million in proceeds in the previous fiscal year. This was mainly attributable to ¥830.188 million in proceeds from the issuance of shares and ¥80.000 million in repayments of short-term borrowings.」

    In addition to the public offering and private placement, 43,400 shares were issued through the exercise of stock acquisition rights, increasing share capital by ¥422.895 million.
  14. FY2019-Q3AdvancedAnnual report

    「The total number of issued shares increased by 33,500 shares to 2,856,300 shares through the exercise of stock acquisition rights between 1 February 2019 and 28 February 2019.」

    The total number of issued shares increased by 33,500 shares through the exercise of stock acquisition rights to 2,856,300 shares. This marked further progress in capital raising following the public offering and private placement at the time of listing.
  15. FY2019-Q2AdvancedAnnual report

    「The total number of issued shares increased by 9,300 shares to 2,822,800 shares through the exercise of stock acquisition rights between 1 November 2018 and 31 December 2018.」

    Following the private placement, the total number of issued shares increased by 9,300 shares through the exercise of stock acquisition rights. Financing activities for the cumulative second quarter also included ¥809.920 million in proceeds from the issuance of shares.
  16. FY2019-Q1AdvancedAnnual report

    「② Type and number of shares to be issued: common shares, 66,700 shares ⑦ Total payment amount: ¥96.381 million ⑨ Payment date: 26 November 2018 ⑩ Use of proceeds: capital increases at subsidiaries, rebuilding of the algorithm research framework and other purposes, and working capital for expanding the scale of operations.」

    Payment for the 66,700 shares issued in the private placement related to the overallotment amounted to ¥96.381 million and was completed on 26 November 2018.
  17. FY2018First statedAnnual report

    「Type and number of shares to be issued: common shares, 420,000 shares」

    In the public offering for which payment was completed on 29 October 2018, the total issue proceeds amounted to ¥606.900 million. The proceeds were scheduled to be allocated to capital increases at subsidiaries, the research framework, ASP functionality, cloud services, recruitment, the accounting system, head office expansion, and advertising and promotional expenses.
Moved together

"Mitigating Seasonal Fluctuations Through Expanded ASP Sales" moved the same way as this thread, in the same document, in 12 of its 17 moves.

12117764★123456
  1. ★This thread
  2. 1Mitigating Seasonal Fluctuations Through Expanded ASP Sales12×
  3. 2Recruiting and Developing Talent11×
  4. 3Maintaining a Sound Financial Base7×
  5. 4Software Development Investment7×
  6. 5Establishment of an Algorithm Research Framework6×
  7. 6Active Expansion Overseas, Primarily in the United States and Europe4×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for VALUENEX Japan yet. It last moved in the General Meetings of Shareholders of 2026-10-06: "Advanced".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Public Offering Capital Increases Accompanying Listings and Allocation of Proceeds to Growth Investments | VALUENEX Japan Inc. (4422) | Komori